证券日报网讯 1月21日，菱电电控发布公告称，2026年1月21日，公司召开第四届董事会第七次会议， 审议通过了《关于使用闲置募集资金进行现金管理的议案》，同意公司使用不超过9，000万元的部分暂 时闲置募集资金进行现金管理，在确保不影响公司募集资金投资进度、有效控制投资风险的前提下，用 于购买安全性高、流动性好的、满足保本要求的投资产品（包括但不限于结构性存款、通知存款、定期 存款、大额存单、收益凭证等），在上述额度范围内，资金可以循环滚动使用，使用期限自公司第三届 董事会第二十六次会议授权期限到期日（2026年3月23日）起12个月之内有效。 （文章来源：证券日报） ...

Trading Information - On January 19, 2026, the stock of Xinmai Medical (688016) closed at 96.73 yuan, down 1.28%, with a turnover rate of 1.17% and a trading volume of 14,500 shares, resulting in a transaction amount of 141 million yuan [1]. Fund Flow - On January 19, the net outflow of main funds was 3.67 million yuan, while the net inflow of retail funds was 10.35 million yuan, and the net outflow of individual investors was 6.67 million yuan [1][3]. Company Announcement - Xinmai Medical announced the approval to use up to 1 billion yuan of temporarily idle raised funds for cash management, investing in high-security and high-liquidity products such as structured deposits, notice deposits, fixed-term deposits, large certificates of deposit, and income certificates. The investment period is within 12 months from the date of board approval, and the funds can be rolled over [1]. - The company committed that this action will not affect the normal implementation of the fundraising investment plan, and the income generated will be used to supplement funding shortages for investment projects and daily operational liquidity [1]. - China International Capital Corporation (CICC) provided a review opinion stating that the planned use of idle funds for cash management does not change the purpose of the raised funds, does not affect the normal implementation of investment projects, and is beneficial for improving fund utilization efficiency without harming the interests of the company and its shareholders [1].

关于使用部分暂时闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 江苏亚虹医药科技股份有限公司（以下简称"公司"或"亚虹医药"）于2026年1月16日召开第二届董事会 第二十次会议，审议通过了《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司在保证 不影响募集资金投资项目实施、募集资金安全的前提下，使用部分暂时闲置募集资金进行现金管理，用 于购买安全性高、流动性好、有保本约定、具有合法经营资格的金融机构销售的投资产品，使用期限自 本次董事会审议通过之日起12个月内有效，在前述额度及期限范围内，公司可以循环滚动使用。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688176 证券简称：亚虹医药 公告编号：2026-002 江苏亚虹医药科技股份有限公司 董事会授权董事长在授权额度和期限内行使现金管理投资决策权并签署相关合同文件，具体事项由公司 财务部负责组织实施。保荐人中信证券股份有限公司（以下简称"保荐人"）对上述事项出具了核查意 见。本事项无需提交股东会审议。现将公司本次 ...

Core Viewpoint - The company, Bangyan Technology, announced the approval of a proposal to use temporarily idle raised funds for cash management, ensuring the safety and normal operation of its fundraising investment plan [2] Group 1: Company Announcement - The fourth meeting of the fourth board of directors will be held on January 9, 2026, to review the cash management proposal [2] - The maximum amount for cash management is set at no more than RMB 150 million, including the principal [2] - The funds can be used to purchase high-security, liquid principal-protected products, such as time deposits and structured deposits [2] Group 2: Fund Management Details - The effective period for the fund usage is 12 months from the date of approval by the first temporary shareholders' meeting in 2026 [2] - Within the specified limit and time frame, the funds can be used in a rolling manner and must be returned to the special account for raised funds upon maturity [2]

Core Viewpoint - The company has approved a plan to utilize temporarily idle raised funds for cash management, ensuring that it does not affect the normal investment plans and guarantees the safety of the funds [1] Group 1: Cash Management Plan - The company will use up to 150 million yuan of temporarily idle raised funds for cash management [1] - The cash management will involve purchasing high-security, liquid principal-protected products, including but not limited to agreement deposits, structured deposits, time deposits, large certificates of deposit, notice deposits, and income certificates [1] - The usage period for these funds is valid for 12 months from the date of approval by the shareholders' meeting, and the funds can be rolled over within the limit [1] Group 2: Impact on Operations - The cash management will not affect the progress of the investment projects funded by the raised funds or the company's normal production and operations [1]

Core Viewpoint - Jinpan Technology announced the approval of a proposal to use part of its temporarily idle raised funds for cash management, ensuring that it does not affect the progress of convertible bond projects or the company's normal operations [2] Group 1: Company Actions - The company will use up to RMB 800 million of temporarily idle raised funds for cash management [2] - The investment products will include low-risk, high-liquidity options such as guaranteed financial products, structured deposits, notice deposits, fixed-term deposits, large certificates of deposit, agreed deposits, and income certificates [2] - The usage period for these funds will not exceed 12 months, and the funds can be rolled over within the specified limit and timeframe [2] Group 2: Financial Management - A dedicated settlement account for cash management of raised funds has been opened recently by the company [2]

Core Viewpoint - The company plans to utilize part of its idle raised funds for cash management, aiming to enhance the efficiency of fund usage while ensuring the safety of the funds and not affecting the normal investment plans [4][6][14] Investment Overview - **Investment Purpose**: To standardize the use and management of raised funds, allowing for reasonable cash management of idle funds without impacting ongoing investment plans and ensuring fund safety [4] - **Investment Amount**: The company intends to use up to RMB 110 million (including principal) for cash management, with a validity period of 12 months from the board's approval [3][9] - **Source of Funds**: The cash management will utilize temporarily idle funds from the company's initial public offering in 2021, with RMB 111.2762 million remaining unused as of June 30, 2025 [4] Investment Method - The company will invest in high-safety, liquid, and capital-preserving financial products, including but not limited to structured deposits, agreement deposits, notice deposits, time deposits, large certificates of deposit, and income certificates [5][6] Decision-Making and Implementation - The board of directors has authorized the chairman and designated individuals to make investment decisions and sign relevant contracts, with the finance department responsible for implementing cash management [6][9] Recent Cash Management Situation - In the past 12 months, the company has also approved cash management for up to RMB 220 million, ensuring that the investment does not affect the progress of investment projects or the company's normal operations [7][8] Risk Control Measures - The company will adhere to relevant regulations and establish a robust approval and execution process for cash management, ensuring the safety of funds [12][13] - The finance department will monitor investment products and take necessary measures to mitigate risks [13] Impact on the Company - The planned cash management will not affect the company's daily cash flow or the normal operation of investment projects, and it aims to improve overall performance and provide better returns for shareholders [11][14]

Core Viewpoint - The company has announced the approval of a plan to utilize part of its temporarily idle raised funds for cash management, emphasizing the safety and liquidity of the investments [1] Group 1: Investment Plan - The company will use up to 500 million yuan of temporarily idle raised funds for cash management [1] - The investment products will include but are not limited to structured deposits, time deposits, large certificates of deposit, and income certificates, all of which meet capital preservation requirements [1] - The usage period for these funds will be from January 9, 2026, to January 8, 2027, with a validity of 12 months and the ability to roll over within the limit [1] Group 2: Impact on Operations - The company emphasizes that this cash management plan will not affect the progress of the raised funds investment projects or the normal production and operation of the company [1]

Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management, specifically not exceeding RMB 0.25 billion, to invest in low-risk, liquid financial products [1] Group 1: Company Actions - The company announced the convening of the 11th Audit Committee meeting and the 15th Board meeting on December 22, 2025, to review the cash management proposal [1] - The funds will be sourced from temporarily idle raised funds and are intended for investment in safe and liquid principal-protected financial products [1] - The approved amount for cash management is valid for 12 months from the date of board approval, and the funds can be rolled over within this limit [1] Group 2: Investment Strategy - The investment direction includes high-security, liquid principal-protected financial products such as structured deposits, agreed deposits, notice deposits, time deposits, large certificates of deposit, and income certificates [1] - The company assures that this cash management initiative will not affect the progress of the raised funds investment projects or the normal production and operation of the company [1]

Group 1 - The company announced plans to utilize up to 7.5 billion yuan of idle raised funds for cash management to improve the efficiency of fund usage [1] - The cash management will be conducted within a 12-month period from the board's approval, allowing for the funds to be used in a rolling manner [1] - The company will invest in low-risk, high-liquidity financial products such as agreed deposits, notice deposits, time deposits, structured deposits, large certificates of deposit, and income certificates [1] Group 2 - Following the announcement, the company's stock price experienced a significant decline, dropping 13.41% to close at 814.88 yuan, after previously rising sharply [3]